Literature DB >> 11696176

Gastric carcinoma with psammomatous calcification after Billroth II reconstruction: case report and literature review.

K Kawahara1, T Niguma, T Yoshino, K Omonishi, S Hatakeyama, S Nakamura, S Hirota, M Motoi.   

Abstract

A case of gastric carcinoma with psammomatous calcification arising in the remnant stomach after Billroth II reconstruction is reported. Borrmann type 1 gastric carcinoma was detected in the remnant stomach of an 82-year-old woman, who had a past history of distal partial gastrectomy for a perforated gastric ulcer, with Billroth II reconstruction at 40 years of age. Histologically, the tumor was a tubular adenocarcinoma that invaded the muscularis propria. Numerous psammoma bodies were found in the lumens of the tumor glands. Dystrophic calcification of gastric cancer is rare and psammomatous calcification of gastric cancer has only been reported in five cases previously. To our knowledge, this is the first case of gastric carcinoma with psammomatous calcification arising in the remnant stomach. We also review previously published reports regarding gastric carcinoma with psammomatous calcification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696176     DOI: 10.1046/j.1440-1827.2001.01257.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Granulomatous hypophysitis with psammoma bodies: a diagnostic dilemma.

Authors:  R Jastania; T Nageeti; K Kovacs; S Ezzat; S L Asa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

2.  Ossifying gastric carcinoid tumor containing bone morphogenetic protein, osteopontin and osteonectin.

Authors:  S I Yamagishi; T Suzuki; H Ohkuro; S Yagihashi
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

3.  Computerized tomography findings in calcified signet-ring gastric cancer receiving chemotherapy: a case report.

Authors:  Ting Wang; Zhi-Yong Lu; Xin-Fei Tu; Shui-Hong Zhang; Fang Huang; Long Huang
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.